Denver Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Denver Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-8,523	Closed	-$3.07M	–	642
2014 Q3	$3.07M	Sell	8,523 -8,755	-51%	-$2.93M	0.1%	215
2014 Q2	$4.88M	Sell	17,278 -19,691	-53%	-$5.84M	0.15%	162
2014 Q1	$11.1M	Buy	36,969 +1,554	+4%	+$479K	0.33%	98
2013 Q4	$9.75M	Sell	35,415 -9,582	-21%	-$2.76M	0.28%	121
2013 Q3	$14.1M	Buy	44,997 +6,687	+17%	+$1.76M	0.3%	112
2013 Q2	$8.62M	Buy	+38,310	New	+$8.92M	0.2%	162

Other funds holding REGN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Denver Investment Advisors's REGN Position: Q4 2014 in Review

Denver Investment Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q4 2014, closing a stake of 8,523 shares — an estimated $3.07M sold.

Denver Investment Advisors first reported a position in REGN in Q2 2013 and held it in 6 quarters. The position peaked at $14.1M in Q3 2013. 512 funds tracked by Wall St. Rank hold REGN as of Q4 2014.

Denver Investment Advisors reported no remaining Regeneron Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
Denver Investment Advisors sold 8,523 Regeneron Pharmaceuticals shares in Q4 2014, an estimated $3.07M.
Denver Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Denver Investment Advisors's Regeneron Pharmaceuticals position peaked at $14.1M in Q3 2013.
512 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2014.

Based on Denver Investment Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.